Adial Pharmaceuticals(ADIL)2025-03-04 13:57Financial Results - Adial Pharmaceuticals, Inc. reported financial results for the fiscal year ended December 31, 2024, in a press release issued on March 4, 2025[5]. - The report does not include specific financial metrics or performance indicators in the provided content[6]. - The financial statements and exhibits are furnished with the Current Report on Form 8-K[7]. Company Information - The company is listed on the Nasdaq Stock Market under the trading symbol ADIL[3]. - The company has not indicated whether it is an emerging growth company[4]. - The report was signed by Cary J. Claiborne, President and Chief Executive Officer of Adial Pharmaceuticals, Inc.[11]. Press Release Details - The press release is attached as Exhibit 99.1 to the Current Report on Form 8-K[5]. - No details on user data, future outlook, or guidance were provided in the available documents[6]. - There is no mention of new products, technologies, market expansion, or mergers and acquisitions in the content[6]. - The report does not specify any new strategies or initiatives undertaken by the company[6].